NYSE:RCUS   Arcus Biosciences, Inc.
Phase 2 data expected 2Q 2021 based on BioPharm catalyst website. Gilead have been buying as well as another insider. Watch for a break of 36.13. Stop signal 26.44. Momentum target.

Like what you see? Get full access to our 3X daily members only video/txt alerts & live trading room at www.smartmoneytrading.com/now

Check out some of our free video examples @ smartmoneytrading.com/insights/
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.